Top 10 Companies in the 3D Biological Printing Industry (2025): Market Leaders Revolutionizing Regenerative Medicine

In Business Insights
June 17, 2025

The Global 3D Biological Printing Market was valued at USD 1.56 Billion in 2024 and is projected to reach USD 3.24 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 12.9% during the forecast period (2024-2030). This remarkable growth is driven by advancements in regenerative medicine, increasing pharmaceutical R&D investments, and expanding applications in drug discovery and personalized therapeutics.

As the biotechnology sector transforms with tissue engineering breakthroughs, leading companies are pushing the boundaries of organ fabrication and medical research. This blog profiles the Top 10 Companies in the 3D Biological Printing Industry—a combination of established leaders and innovative disruptors shaping the future of healthcare.


🔟 10. Voxeljet

Headquarters: Friedberg, Germany
Key Offering: Industrial-scale 3D bioprinting systems

Voxeljet brings industrial 3D printing expertise to biomedical applications, specializing in large-format systems for tissue scaffolding and pharmaceutical testing platforms.

Technological Advancements:

  • High-speed binder jetting for porous scaffold fabrication
  • Material compatibility with hydrogel formulations
  • 50μm resolution precision for complex biological structures

Download FREE Sample Report: Global 3D Biological Printing Market – View in Detailed Research Report


9️⃣ 9. Stratasys

Headquarters: Eden Prairie, Minnesota, USA
Key Offering: Multi-material PolyJet bioprinting

Stratasys applies its industrial 3D printing expertise to medical applications, providing advanced anatomical modeling solutions for surgical planning and medical education.

Technological Advancements:

  • J750 Digital Anatomy Printer with tissue-realistic properties
  • Six+ material printing capability
  • FDA-cleared medical device production

8️⃣ 8. Solidscape

Headquarters: Merrimack, New Hampshire, USA
Key Offering: Ultra-high precision bioprinting molds

Solidscape delivers micro-precision wax printing for creating molds used in dental, orthopedic, and research applications requiring biocompatible materials.

Technological Advancements:

  • 5μm layer resolution capabilities
  • Medical-grade material compatibility
  • Automated post-processing systems

7️⃣ 7. Oceanz 3D Printing

Headquarters: Ede, Netherlands
Key Offering: Custom bioprinting services

Oceanz offers comprehensive 3D bioprinting services to research institutions, specializing in patient-specific anatomical models and research scaffolds.

Technological Advancements:

  • Bio-compatible polymer expertise
  • ISO 13485 certified medical production
  • Multi-jet fusion for complex geometries

6️⃣ 6. Bio3D Technologies

Headquarters: Singapore
Key Offering: Vascularized tissue printing solutions

Bio3D Technologies specializes in vascular network printing with its NovoGen MMX Bioprinter, addressing critical challenges in organ fabrication.

Technological Advancements:

  • Automated tissue maturation systems
  • Functional vascular network printing
  • Proprietary bioink formulations

Download FREE Sample Report: Global 3D Biological Printing Market – View in Detailed Research Report


5️⃣ 5. Materialise NV

Headquarters: Leuven, Belgium
Key Offering: Integrated biomedical 3D solutions

Materialise provides a complete ecosystem of 3D printing software and services for medical applications, from surgical planning to FDA-cleared implant design.

Technological Advancements:

  • Mimics Innovation Suite for medical imaging
  • 80+ FDA-cleared medical devices
  • Global network of certified medical 3D facilities

4️⃣ 4. EnvisionTEC

Headquarters: Dearborn, Michigan, USA
Key Offering: Ultra-high resolution bioprinters

Now part of Desktop Metal, EnvisionTEC’s bioplotters enable precise deposition of cells, hydrogels, and biomaterials for research and clinical use.

Technological Advancements:

  • Multi-material extrusion capabilities
  • Sterile environment options
  • Temperature-controlled material deposition

3️⃣ 3. CELLINK (Now BICO)

Headquarters: Gothenburg, Sweden
Key Offering: Comprehensive bioprinting ecosystem

CELLINK has emerged as a bioprinting leader through strategic acquisitions and its open-source bioink platform, offering end-to-end solutions.

Technological Advancements:

  • First universal bioink
  • Automated cell culture integration
  • High-throughput robotic systems

2️⃣ 2. Organovo

Headquarters: San Diego, California, USA
Key Offering: ExVive Human Tissue Models

A pioneer in functional human tissue printing, Organovo develops therapeutic tissues and validated preclinical testing platforms for pharmaceutical research.

Technological Advancements:

  • 3D human liver tissues for drug testing
  • Patented tissue maturation process
  • Functional vascular networks

1️⃣ 1. Allevi (Part of 3D Systems)

Headquarters: Philadelphia, Pennsylvania, USA
Key Offering: Complete bioprinting workflows

Allevi leads the market with integrated hardware, software, and bioink systems that streamline the transition from concept to 3D tissue models.

Technological Advancements:

  • AI-powered print optimization
  • Real-time tissue monitoring
  • Six+ material printing capacity

Get Full Report Here: Global 3D Biological Printing Market – View in Detailed Research Report


🔬 Outlook: The Future of 3D Biological Printing

The bioprinting market is transitioning from research labs to clinical applications with increasing regulatory approvals and standardization.

🧪 Key Trends Shaping the Market:

  • Increasing FDA/EU approvals for 3D printed medical implants
  • Convergence of AI with bioprinting for predictive modeling
  • $1.2B+ venture funding in bioprinting startups since 2020
  • Pharmaceutical adoption of organ-on-chip technologies

Get Full Report Here: Global 3D Biological Printing Market – View in Detailed Research Report

These innovators are advancing human healthcare through revolutionary tissue engineering technologies that promise to transform medicine.